AI Summary & Key Takeaways
AI InsightResults: The overall survival of the patients with advanced disease in the surgery group was statistically higher than those in the chemoradiotherapy group.
📌 3 Key Takeaways
Abstract
Objectives: This study aims to evaluate the efficacy chemoradiotherapy and surgical treatment in patients with hypopharyngeal cancer. Patients and Methods: Between January 2003 and July 2009, 48 patients (31 males, 17 females; mean age 55.5±13.4 years; range 29 to 84 years) who were diagnosed with hypopharyngeal cancer were retrospectively evaluated. The patients were assigned into surgery (n=17) and chemoradiotherapy (n=31) groups. Results: The overall survival of the patients with advanced disease in the surgery group was statistically higher than those in the chemoradiotherapy group. The recurrence rate of the patients was 35.3% in the surgery group, whereas it was 41.4% in the chemoradiotherapy group. Conclusion: Our study results indicated that the survival rates were higher in the surgery group. On the other hand, chemoradiotherapy had the advantage of laryngeal preservation.
Özet
Amaç: Bu çalışmada hipofarenks kanserli hastalarda kemoradyoterapinin ve cerrahi tedavinin etkinliği değerlendirildi. Hastalar ve Yöntemler: Ocak 2003 - Temmuz 2009 tarihleri arasında hipofarenks kanseri tanısı konulan 48 hasta (31 erkek, 17 kadın; ort. yaş 55.5±13.4 yıl; dağılım 29-84 yıl) retrospektif olarak değerlendirildi. Hastalar cerrahi (n=17) ve kemoradyoterapi (n=31) gruplarına ayrıldı. Bulgular: İleri evre hastalığı olan hastalarda genel sağkalım oranları, cerrahi grupta kemoradyoterapi grubuna göre istatistiksel olarak daha yüksekti. Hastaların nüks oranları cerrahi grupta %35.3, kemoradyoterapi grubunda ise %41.4 idi. Sonuç: Çalışma bulgularımız sağkalım oranının cerrahi grubunda daha yüksek olduğunu göstermiştir. Diğer yönden, kemoradyoterapi larenksin korunabilmesi ile ön plana çıkmıştır.